Ativa Raises $15 Million from China Investors for Micro Blood Test Device

Ativa Medical of Minneapolis, a medical diagnostic device company, raised $15 million in a B round, much of it from China investors. The company is developing the Ativa micro lab device, which miniaturizes larger, more expensive central lab blood test devices into a countertop system for use in a clinic. Results are available in five minutes. The financing was led by Ping An Ventures, the VC arm of the large China insurance company, and joined by Hermed Capital, a partnership between Fosun Pharma and SK Group of Korea; and DiAn Diagnostics, an operator of China central labs. More details.... Stock Symbols: (SHA: 600196; HK: 2196) (SHZ: 300244) Share this with colleagues: // //